Upcoming clariti launches: next-generation multifocal in EMEA and Asia Pac, plus toric and multifocal in Japan.
MyDay private-label and branded contract wins are expected to convert into stronger CooperVision growth in fiscal Q3 and Q4.
Expansion of MyDay MiSight across EMEA, Asia Pac and Canada during fiscal 2026.
CooperSurgical fertility expected to grow mid-single digits in the back half of fiscal 2026, supported by capital placements and consumable pull-through.
Raised fiscal 2026 free-cash-flow outlook to about $650 million, excluding litigation payouts.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for The Cooper Companies, Inc. and 4,900+ companies.